Ibbl (integrated Biobank Of Luxembourg)

What Ibbl (integrated Biobank Of Luxembourg) does

The Integrated Biobank of Luxembourg (IBBL) is a not-for-profit biobanking unit within the Luxembourg Institute of Health (LIH), operating from the Translational Medicine Operations Hub (TMOH) in Luxembourg. Established in 2009, IBBL provides comprehensive biospecimen management services spanning the full sample lifecycle: collection, transport, processing, storage, and distribution. The organization is structured into five specialized teams — Biorepository (storage and logistics), Biorefinery (sample processing and analysis), National Cytometry Platform (single-cell technologies), Scientific Equipment Management (equipment lifecycle), and Biospecimen Science (quality improvement research).

IBBL's infrastructure includes cold rooms at +4°C and -20°C, -80°C freezers, LN2 tanks, and independent 24/7 environmental monitoring with backup systems. A Laboratory Information Management System (LIMS) ensures full traceability of biospecimens and their pre-analytical conditions. The organization holds ISO 17025 accreditation, ISO 9001:2015 quality management certification, and ISO 20387 biobanking accreditation (awarded by UKAS in 2024), positioning it as one of the few internationally accredited biobanks for biomedical research.

IBBL operates as a sales-led service organization serving academic research institutions, EU research consortia, and industry partners (primarily pharmaceutical and biotechnology) through direct collaborative agreements. Revenue is generated through professional service provision under custom contracts, supplemented by public research funding via its parent LIH. The organization explicitly targets prevention of pre-analytical bias and supports reproducibility in scientific research through standardized, validated, and optimized processes.

Name

Ibbl (integrated Biobank Of Luxembourg)

Legal name

Integrated Biobank of Luxembourg (IBBL)

Website

https://ibbl.lu

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

IBBL is a not-for-profit biobanking unit within the Luxembourg Institute of Health, providing ISO-accredited biospecimen collection, processing, storage, and analysis services to academic researchers, EU consortia, and industry partners.

Ownership category

akta.pro rank

Product category

Biobanking Services

NAICS

Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biobank & Biospecimen Management LIMS (HLACAMAG)

Keywords

• Biospecimen management services
• Biobanking services
• Biorepository services
• Sample processing services
• Clinical trial support

Headquarters

HQ city

Luxembourg

HQ country

Luxembourg

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Others

Revenue model

1. Service Provision: As a not-for-profit unit dedicated to service provision in the biomedical sector, IBBL generates revenue through providing biospecimen management services to academia, EU consortia, and industry. The organization is part of Luxembourg Institute of Health and operates with public funding support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

IBBL provides an integrated, comprehensive solution for all stages of the biospecimen journey, covering collection, transport, processing, storage, and distribution of biological samples. Operating as a not-for-profit unit within the Luxembourg Institute of Health, the organization delivers standardized, validated, and optimized biospecimen management services to academia, EU consortia, and industry through five specialized teams (Biorepository, Biorefinery, National Cytometry Platform, Scientific Equipment Management, and Biospecimen Research).

Product overview

IBBL is a not-for-profit biobank offering an integrated, comprehensive solution for all stages of the biospecimen journey—collection, processing, storage, and distribution. The organization operates five specialized teams: Biorepository (biospecimen storage and logistics), Biorefinery (sample processing and analysis), National Cytometry Platform (single-cell technologies), Scientific Equipment Management (equipment lifecycle), and Biospecimen Research (quality improvement research). With over 15 years of experience, IBBL supports academia, EU consortia, and industry with standardized, validated, and optimized processes governed by a robust Quality Management System.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Prevention of pre-analytical bias through standardization
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• EuroBioBank: EuroBioBank is a European network of biobanks focused on rare disease biospecimens, coordinated across multiple academic institutions. Structurally comparable to IBBL as a European, non-profit, networked biobanking infrastructure.
• BioIVT: BioIVT is a leading commercial biospecimen provider offering human tissue, biofluids, and cellular products to pharma, biotech, and academic researchers. Directly comparable to IBBL's biorepository and biorefinery services, but operating at significantly larger commercial scale globally.
• Indivumed: Indivumed operates a clinical biobank and provides biomarker services for oncology research, with a focus on annotated, high-quality biospecimens. Comparable to IBBL's integrated biobank-plus-analysis model but with a more commercial orientation and oncology focus.
• UK Biobank: UK Biobank is a large-scale, non-profit population biobank with ~500,000 participants. The most structurally comparable peer to IBBL's not-for-profit, public-funded model, though at far greater scale and with a population cohort focus.
• Cureline: Cureline is a global biospecimen provider offering human tissue, primary cells, and biofluids for translational research. Comparable to IBBL's biorepository model but with a stronger commercial focus and broader global supplier network.
• Tissue Solutions: Tissue Solutions supplies ethically sourced human tissue and biofluid samples to researchers, with a focus on quality and regulatory compliance. Comparable to IBBL's biospecimen collection and distribution services from a commercial supplier perspective.
• Brooks Life Sciences (Hamilton Storage): Hamilton Storage (formerly Brooks Life Sciences) provides automated biobanking storage, sample management software, and repository services. Overlaps with IBBL's biorepository operations and brings commercial-scale automation that IBBL's smaller operation cannot match.

Broad incumbents

• Medpace: Medpace is a global clinical contract research organization offering biobanking and central laboratory services as part of broader clinical trial solutions. Provides overlapping capabilities with IBBL but as part of a full-service CRO platform.

Emerging players

• iSpecimen: iSpecimen operates a marketplace for biospecimen procurement, connecting researchers with biobank suppliers. Adjacent to IBBL's model but focused on aggregation and platform rather than direct biobank operations.
• ReproCELL (now part of Axol Bioscience): ReproCELL provides iPSC, biobanking, and primary cell services to drug discovery researchers. Comparable to IBBL's biorefinery and biospecimen processing capabilities, with a stronger commercial and iPSC focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ibbl-integrated-biobank-of-luxembourg

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ibbl (integrated Biobank Of Luxembourg)